Subject
Clinical Neurology,Neurology,General Medicine
Reference105 articles.
1. Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East;Achiron;BMC Neurol.,2017
2. Systematic review of depression in patients with multiple sclerosis and its relationship to interferon treatment;Alba Palé;Mult. Scler. Relat. Disord.,2018
3. Tratamiento de la esclerosis múltiple remitente recurrente con fingolimod en la práctica clínica habitual;Alcalá-Vicente;Rev de Neurol.,2017
4. Combination treatment of fingolimod with antidepressants in relapsing–remitting multiple sclerosis patients with depression: a multicentre, open-label study – REGAIN;Bayas;Ther. Adv. Neurol. Disord.,2016
5. Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumab;Bianco;Eur. Neurol.,2015
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献